Mexico

BMI View: Given Mexico's uncertain macroeconomic outlook, pharmaceutical companies in the country will optimise revenue growth potential in the medium term by increasing their market... 2010-08-11

As a result of the investigations launched in February 2010, the Mexican Federal Competition Commission (CFC) decided to fine six pharmaceutical companies - Eli Lilly, Probiomed, Laboratorios... 2010-06-25

Mexican holding company Grupo Casa Saba (GCS) is acquiring Santiago-based Farmacias Ahumada (FASA) in a deal worth approximately US$637mn, including the additional assumption of US$162mn... 2010-05-21

Reversing the usual trend of Mexican pharmaceutical firms investing in its home market, Guatemalan pharmaceutical company Pharma Group has installed a US$25mn laboratory in the south-eastern... 2010-05-20

BMI Core View: Corporate social responsibility (CSR) is an under-appreciated business activity in the pharmaceutical industry. Like all commercial entities, drugmakers are fully entitled... 2010-05-07

The Mexican healthcare reform, following the roll out of the Seguro Popular subsidised healthcare scheme has enjoyed ongoing success. The secretary of health in Mexico has stated... 2010-04-15

New procedures are being introduced in Mexico to prevent the sale of antibiotics without prescription. The health department wants to ensure that the law on antibiotic sales, which... 2010-03-29